Daily non-political popular news in brief.

New treatment offers relief from chronic back pain

Chronic back pain is a condition that affects a significant part of the population, with patients falling into three major groups; those with herniated discs, spinal stenosis (a nerve affecting narrowing of the spinal cord), and complications from failed back surgery. Radiofrequency thermolesioning is a widespread treatment for chronic back pain, but because of its neurodestructive nature, it is often considered an unsuitable treatment.

Read more »

Keywords: treatment, offers, relief, chronic, pain, offer

« Previous | Next »

Similar news on "New treatment offers relief from chronic back pain":

1. TB medication offers pain relief
   08-04-2007 · Science News Online
   An antibiotic once used to treat tuberculosis may offer relief from chronic pain.
   Similar news · Read more »
   
2. Swell gel could bring relief to back pain sufferers
   03-19-2007 · EurekAlert!
   Scientists at the University of Manchester believe injections of tiny sponge-like particles could provide an alternative to major surgery in the treatment of chronic lower back pain.
   Similar news · Read more »
   
3. Researchers find relief for chronic pain
   01-21-2008 · EurekAlert!
   Researchers in the Department of Medicine and Department of Neurosciences at Mount Sinai School of Medicine have discovered that chronic pain can be successfully treated with novel targeted gene therapy. In an effort to find a more effective treatment for chronic pain, researchers at Mount Sinai developed a gene therapy technique that simulates the pain-killing effect of opiate drugs.
   Similar news · Read more »
   
4. Gene therapy offers new hope for treatment of peripheral neuropathy
   05-31-2007 · EurekAlert!
   Researchers from the University of Pittsburgh School of Medicine report that they have successfully used gene therapy to block the pain response in mice with neuropathic pain, a type of chronic pain in people for which there are few effective treatments. These findings are being presented at the 10th annual meeting of the American Society of Gene Therapy, being held May 30 to June 3 at the Washington State Convention & Trade Center, Seattle.
   Similar news · Read more »
   
5. Methadone even at therapeutic levels can kill
   01-09-2008 · EurekAlert!
   Methadone is a possible cause of sudden cardiac death even when it isn't overdosed but is taken at therapeutic levels primarily for relief of chronic pain or drug addiction withdrawal, a new study by Oregon Health & Science University researchers suggests.
   Similar news · Read more »
   
6. Commonly used drug offers promise for premature babies
   05-17-2007 · EurekAlert!
   Scientists have found evidence that the cox-2 inhibitor celecoxib, a common pain reliever used to treat arthritis, may offer a new way to reduce the risk of the most common cause of brain damage in babies born prematurely.
   Similar news · Read more »
   
7. Phase II study shows HRPC patients with bone metastases see improved survival with ZD4054
   09-25-2007 · EurekAlert!
   New Phase II data presented today suggest that ZD4054, a novel compound in development for the treatment of men with hormone-resistant prostate cancer, could offer a promising improvement in overall survival in men with metastatic HRPC who were asymptomatic or mildly symptomatic for pain.1 Patients who received ZD4054 10mg once-daily experienced a 45 percent reduction in the risk of death compared to placebo.
   Similar news · Read more »
   
8. Gabapentin shown effective for fibromyalgia pain
   06-11-2007 · EurekAlert!
   New research supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases shows that the anticonvulsant medication gabapentin, which is used for certain types of seizures, can be an effective treatment for the pain and other symptoms associated with the common, often hard-to-treat chronic pain disorder, fibromyalgia.
   Similar news · Read more »
   
9. Pain treatment in the field: Good for soldiers' comfort and better for rebuilding troop strength
   12-17-2007 · EurekAlert!
   Noncombat-related acute and recurrent chronic pain are the leading causes of soldier attrition in modern war, with the return-to-duty rate as low as 2 percent when these soldiers are treated outside the theaters of operation. However, that rate jumps to 95 percent when troops and officers are treated and managed for pain in the field of instead of being sent elsewhere for therapy, according to a new study from a Johns Hopkins anesthesiologist.
   Similar news · Read more »
   
10. Progress toward an alternative for EPO: Gas6 offers remedy where EPO fails today
    01-31-2008 · EurekAlert!
    Many patients with a chronic disease or cancer have to contend with anemia. At present, the hormone EPO is administered to a large number of these patients to alleviate the anemia. But unfortunately, treatment with EPO is not always effective. VIB scientists have been researching the role of the Gas6 protein. This substance has proven successful in the treatment of mice with anemia. In addition, Gas6 contributes to a reinforcement of EPO's effect.
    Similar news · Read more »